Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imipenem-Relebactam PK in ARC
NCT04147221Phase 1Completed
- Sponsor
- Hartford Hospital
- Start
- Feb 2020
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of imipenem and relebactam in sepsis, sponsored by Hartford Hospital. Primary endpoints: Imipenem Clearance at 6 hours and Relebactam Clearance at 6 hours. Started Feb 2020; status: completed.
02
Drugs
imipenemrelebactam
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT04147221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04147221.